Surajeet Das Gupta &Amp; Sohini Das

Stories by Surajeet Das Gupta &Amp; Sohini Das

ISPs find work-from-home has boosted demand for data

ISPs find work-from-home has boosted demand for data

Rediff.com   22 Mar 2020

Feedback from telecom members indicated a 10 per cent increase in traffic, but no fears of choked networks. Telcos currently use 65-70 per cent of the network capacity. In other words, they have enough additional capacity to handle the new pressure without clogging the system.

Coronavirus spread: Retailers, multiplexes, mall owners spar over rentals

Coronavirus spread: Retailers, multiplexes, mall owners spar over rentals

Rediff.com   20 Mar 2020

Retailers and multiplex operators want mall owners to either forgo rent for the period of the shutdown or lower rent in the event the mall is open but footfalls are low.

How companies deal with coronavirus panic

How companies deal with coronavirus panic

Rediff.com   17 Mar 2020

Employees asked to work from home... cancelled travel plans... curtailed meetings... Caution and precaution dominate Corporate India's response to Covid-19.

Coronavirus fear robs malls, multiplexes of Holi colour

Coronavirus fear robs malls, multiplexes of Holi colour

Rediff.com   8 Mar 2020

'There is a clear business impact. People are avoiding crowded places and gatherings across cities. This is hitting business, both at traditional and modern trade outlets, during the Holi season, which kicked off from Saturday,' says Praveen Khandelwal, general secretary, Confederation of All India Traders (CAIT).

Coronavirus impact: Govt restricts exports of 13 APIs, formulations

Coronavirus impact: Govt restricts exports of 13 APIs, formulations

Rediff.com   4 Mar 2020

Exports of 13 APIs - including paracetamol, tinidazole, metronidazole, vitamin B1, vitamin B6, vitamin B12, acyclovir, progesterone - along with formulations made from these APIs, would be restricted.

Ambani vs Chandra: Media convergence set for a new game

Ambani vs Chandra: Media convergence set for a new game

Rediff.com   28 Feb 2020

In terms of market capitalisation, Zee alone has a market cap of Rs 24,000 crore compared to Rs 15,000 crore of the merged Reliance entity.

The billion-dollar question before Vodafone Group

The billion-dollar question before Vodafone Group

Rediff.com   24 Feb 2020

Based on Statista data for 2019, Vodafone has 17.2 million subscribers in the UK, 29.5 million in Germany, and over 13.7 million in Spain. Without Voda Idea, the Group will become smaller than Airtel and Jio.

What consolidation of telcos mean for the customers

What consolidation of telcos mean for the customers

Rediff.com   20 Feb 2020

The Indian market is more in sync with mobile markets of advanced countries like the UK, Japan, and South Korea, where there are fewer players - three to four.

Coronavirus outbreak: Domestic drug market stares at supply crisis

Coronavirus outbreak: Domestic drug market stares at supply crisis

Rediff.com   20 Feb 2020

Big pharma companies, however, said while it was true that formulation players would not rush to buy raw material, they could not afford losing customers.

Kohli is top celebrity brand for third time in a row

Kohli is top celebrity brand for third time in a row

Rediff.com   17 Feb 2020

The Duff & Phelps report shows that Virat Kohli has increased his brand value by 40 per cent to $237.5 million in 2019 and taken a huge lead with his closest rival, Akshay Kumar, ranked second.

Coronavirus scare: India may soon run short of antibiotics, diabetes drugs

Coronavirus scare: India may soon run short of antibiotics, diabetes drugs

Rediff.com   12 Feb 2020

Indian pharmaceutical companies are heavily dependent on China to source fermentation-based active pharmaceutical ingredients and intermediates to manufacture these medicines, but the coronavirus outbreak there has disrupted the supply.

Medical devices to be treated as drugs from next fiscal

Medical devices to be treated as drugs from next fiscal

Rediff.com   12 Feb 2020

The new regime aims to bring in ease of doing business, as the NITI Aayog has proposed to do away with the need to have manufacturing licences to register medical devices or to get a certificate of compliance.

Coronavirus: Windfall likely for medical device firms

Coronavirus: Windfall likely for medical device firms

Rediff.com   7 Feb 2020

As fear grips the world, demand for protective gear used by health care professionals and citizens is on a rise. And, supply disruption from China has opened a window of opportunities for Indian medical device makers.

Telcos, DoT discuss part paying AGR ahead of SC ruling

Telcos, DoT discuss part paying AGR ahead of SC ruling

Rediff.com   28 Jan 2020

The companies have offered to pay upfront the principal amount due for licence fees and spectrum usage charges (SUCs) on the basis of adjusted gross revenue (AGR). This amount will not include the interest, the penalty, and the interest on the penalty.

The little-known company that's buying up distressed telcos

The little-known company that's buying up distressed telcos

Rediff.com   24 Jan 2020

UV Asset Reconstruction Company Ltd has made the highest bid of Rs 16,000 crore to buy Anil Ambani group's Reliance Communications and Reliance Telecom, which are in the National Company Law Tribunal (NCLT). Last year it was the highest bidder for taking over Aircel's assets for an upfront payment of Rs 150 crore. Surajeet Das Gupta and Dev Chatterjee dig deeper to find out more about this little known company.

Adamant Trai says will implement new tariff order by March 1

Adamant Trai says will implement new tariff order by March 1

Rediff.com   14 Jan 2020

Reiterating its position, TRAI, which oversees both the telecom and television sectors in the country, said the amendments suggested on January 1 had been done to correct "distortions" in the market and address pricing issues.

Price relief for diabetes patients as drugs go off patent

Price relief for diabetes patients as drugs go off patent

Rediff.com   13 Jan 2020

At least two key drugs in the gliptin category have already gone off patent and cheaper variants are crowding the market. Also, several patent expiries are round the corner for the newest category of drugs - SGLT-2 inhibitors or gliflozins.

Why Yes Bank audit committee chief quit

Why Yes Bank audit committee chief quit

Rediff.com   13 Jan 2020

Uttam Prakash Agarwal alleged that Citax and Braich offers were incomplete and did not include firm commitment as to the price, size, timings, confirmation from the banks about availability of the funds.

How Avengers stole the Indian box office

How Avengers stole the Indian box office

Rediff.com   1 Jan 2020

'If you look at the Number 1 film in India this year across Bollywood and other regional film industries, it is Avengers: Endgame.'